Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Scandinavian Journal of Clinical and Laboratory Investigation|July 8, 2015
Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometryChristian Schoergenhofer, Michael Schwameis, Martin Brunner, et al.Clinical and Translational Science|May 3, 2026
A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EUSophie Brunner Ziegler, Fabian Eibensteiner, Nina Reumann, et al.Rheumatology International|August 4, 2026
Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud's phenomenon: a retrospective analysisMarkus Müller, Michael E Gschwandtner, Hans Kiener, et al.Human Vaccines & Immunotherapeutics|April 17, 2023
Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case seriesMarcus Lisy, Nikolaus Urban, Sophie Brunner-Ziegler, et al.Scientific Reports|September 29, 2025
A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemiaSophie Brunner-Ziegler, Moritz Staudacher, Christian Schörgenhofer, et al.Gene|June 5, 2013
CYP2C9 genotype and association with bone mineral density: a pilot studySophie Brunner-Ziegler, Georgiana-Aura Giurgea, Raute Sunder-Plassmann, et al.Vascular Medicine (London, England)|February 9, 2024
Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasmsSophie Brunner-Ziegler, Eva Dassler, Markus Müller, et al.British Journal of Haematology|August 22, 2014
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot studySophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, et al.Journal of Infection and Public Health|February 26, 2023
Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factorsSophie Brunner-Ziegler, Martin Bäuerle, Peter Brühl, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 16, 2021
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccinesSophie Brunner-Ziegler, Tibor Spath, Gabriela Kornek, et al.Pageof 3